STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, said its analytical service unit (ASU) in Shanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have passed two inspections from the U.S. FDA within the same week, with no Form 483s issued.   “It’s a point of great pride that our quality systems allow us to be inspected at short notice by any applicable regulatory agency in the world. In this case, we received...